Pink parties. Pink Ribbons. Pink celebrations. Pink boas. Pink bagels. You name it, it's pink in October. Many people, breast cancer patients and others, find empowerment and emotional comfort in "pink." Many feel as if they have done good by participating or buying a "pink" good. As I've mentioned before in my post, Missed Opportunities: Celebrities … Continue reading Dying for a cure this Pinktober: Metastatic Breast Cancer Awareness
This is excellent work by METAvivor, the sole US organization dedicated to awarding funding for stage IV breast cancer research. This October let’s take action. Let’s help fund research for the 30% of women who develop metastatic breast cancer. Did you know that metastatic disease only receives 2% of breast cancer research funding? That’s not a typo. 2%. Or, did you know that outcomes haven’t changed for metastatic patients in 10 years? Please, watch this video, all the way to the end, and if you want to make a difference this October, don’t just shop pink. Give money to organizations like METAvivor, that directly fund research for patients.
Last week marked a very exciting moment for anyone with any involvement in breast cancer patient care, including, and especially, for breast cancer patients. On February 22 2013, the FDA approved Kadcyla, a new treatment for HER-2 positive metastatic breast cancer. Kadcyla was formerly known to many in the cancer world as T-DM1 and has … Continue reading New hope in HER-2 Positive Metastatic Breast Cancer